Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implication of Cardiac Shock Wave Therapy on Coronary Artery Disease: A Prospective Randomized Double-blind Control Trial

NCT03053128 is registered in ClinicalTrials.gov with Beijing Hospital as lead sponsor.

NCT NCT03053128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03053128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implication of Cardiac Shock Wave Therapy on Coronary Artery Disease: A Prospective Randomized Double-blind Control Trial
Lead sponsor
Beijing Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 20, 2017
Completion date
November 20, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac ischemia